HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY
Hikma Pharmaceuticals is a London Stock Exchange-listed multinational company that develops, manufactures, and markets branded and non-branded generic pharmaceutical products across the US, Europe, and the Middle East and North Africa.
Get an alert when HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£163M
USD 217,000,000
+15.4% vs 2024
Net assets
£2.4B
USD 3,176,000,000
-4.4% vs 2024
Employees
9,603
+3.2% vs 2024
Profit before tax
£486M
USD 647,000,000
+1.7% vs 2024
Net assets
2-year trend · vs Health Care median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £2,350,597,610 | £2,517,477,261 | +7.1% | |
| Operating profit | £540,479,591 | £525,445,388 | -2.8% | |
| Profit before tax | £478,087,649 | £486,356,461 | +1.7% | |
| Net profit | £374,351,650 | £381,868,751 | +2% | |
| Cash | £141,321,506 | £163,121,101 | +15.4% | |
| Total assets less current liabilities | £2,891,828,911 | £3,181,237,315 | +10% | |
| Net assets | £2,497,932,797 | £2,387,431,406 | -4.4% | |
| Equity | £1,744,719,236 | £2,026,610,539 | +16.2% | |
| Average employees | 9,308 | 9,603 | +3.2% | |
| Wages | £343,531,534 | £364,579,418 | +6.1% | |
| Directors' remuneration | £44,350,898 | £44,350,898 | 0% |
Figures converted to GBP from USD at 0.752 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating margin | 23.0% | 20.9% | |
| Net margin | 15.9% | 15.2% | |
| Return on capital employed | 18.7% | 16.5% | |
| Gearing (liabilities / total assets) | 35.3% | 44.0% | |
| Current ratio | 1.76x | 1.84x | |
| Interest cover | 7.73x | 6.59x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 2 times since incorporation
- HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY 2005-10-28 → present
- HIKMA PHARMACEUTICALS PLC 2005-09-19 → 2005-10-28
- HIKMA PHARMA PUBLIC LIMITED COMPANY 2005-09-08 → 2005-09-19
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Consolidated group
- Auditor
- PricewaterhouseCoopers LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors have made a reasonable expectation that the Group has adequate resources to continue in operational existence for a period of at least twelve months from the date of approval of the financial statements and therefore continue to adopt the going concern basis in preparing the financial statements, with no material uncertainties.”
Group structure
- HIKMA PHARMACEUTICALS PUBLIC LIMITED COMPANY · parent
- Al Jazeera Pharmaceuticals S.A.R.L. 99%
- Hikma Pharmaceuticals Industries S.A.E 100%
- Hubei Haosun Pharmaceutical Co. Ltd. 49%
- Hikma Pharma S.A.E 100%
- Hikma for Importation Co. LLC 100%
Significant events
- “On 20 February 2026, Hikma announced a share buyback programme of up to $250 million to be executed during 2026.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
10 active · 19 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MIDDLEMIST, Helen | Secretary | 2024-01-01 | — | — |
| AL HUSRY, Ali Mohammed | Director | 2005-10-14 | Apr 1957 | Jordanian |
| BALAN, Laura Mihaela | Director | 2022-10-01 | Jan 1978 | British |
| DARWAZAH, Mazen Samih | Director | 2005-09-08 | Jun 1958 | Jordanian |
| DARWAZAH, Said Samih | Director | 2007-07-01 | May 1957 | Jordanian |
| FLOWERS, Cynthia Louise | Director | 2019-06-01 | Feb 1960 | American |
| HULL, Victoria Mary | Director | 2022-11-01 | Mar 1962 | British |
| HURT, Douglas Malcolm | Director | 2020-05-01 | Jun 1956 | British |
| NABILSI, Khalid Walid Hussni | Director | 2025-12-15 | Feb 1972 | Jordanian |
| VOJTA, Deneen, Dr | Director | 2022-11-01 | Aug 1964 | American |
Show 19 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| ARKHAGHA, Hussein Omar | Secretary | 2022-06-15 | 2024-01-01 |
| KNOWLES, Henry James | Secretary | 2005-09-08 | 2012-04-03 |
| SPEIRS, Peter Alexander | Secretary | 2012-04-03 | 2022-06-15 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Secretary | 2005-09-08 | 2005-09-08 |
| ASHTON, Michael Richard Dwyer | Director | 2005-10-14 | 2017-05-19 |
| BUTLER, Patrick Noel | Director | 2014-04-01 | 2024-02-29 |
| BYRNE, Breffni John | Director | 2005-10-14 | 2016-05-12 |
| CASTELLANI, John Julius | Director | 2016-03-01 | 2025-04-24 |
| DARWAZAH, Samih Taleb | Director | 2005-09-08 | 2014-05-15 |
| GANN, Jochen | Director | 2016-02-29 | 2020-06-25 |
| GOODE, Ronald Lane, Dr | Director | 2006-12-12 | 2018-05-18 |
| HENDERSON, Mary Regina | Director | 2016-10-01 | 2025-12-31 |
| KIRBY, Pamela Josephine, Dr | Director | 2014-12-01 | 2022-04-25 |
| MISHLAWI, Riad Ali | Director | 2023-09-01 | 2025-12-15 |
| OLAFSSON, Sigurdur Oli | Director | 2018-02-20 | 2022-06-24 |
| PICKERING, Robert Mark | Director | 2011-09-01 | 2020-12-18 |
| ROWE HAM, David, Sir | Director | 2005-10-14 | 2014-05-15 |
| INSTANT COMPANIES LIMITED | Corporate Director | 2005-09-08 | 2005-09-08 |
| SWIFT INCORPORATIONS LIMITED | Corporate Nominee Director | 2005-09-08 | 2005-09-08 |
Ownership
Persons with significant control
Filing timeline
Last 20 of 375 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-05-08 RESOLUTIONS Resolution
- 2024-05-02 RESOLUTIONS Resolution
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-05-04 | AA | accounts | Accounts with accounts type group | |
| 2026-04-28 | SH06 | capital | Capital cancellation shares | |
| 2026-04-28 | SH06 | capital | Capital cancellation shares | |
| 2026-04-28 | SH03 | capital | Capital return purchase own shares | |
| 2026-04-28 | SH03 | capital | Capital return purchase own shares | |
| 2026-04-10 | SH03 | capital | Capital return purchase own shares | |
| 2026-04-08 | SH03 | capital | Capital return purchase own shares | |
| 2026-03-25 | CH01 | officers | Change person director company with change date | |
| 2026-01-06 | TM01 | officers | Termination director company with name termination date | |
| 2025-12-27 | AP01 | officers | Appoint person director company with name date | |
| 2025-12-15 | TM01 | officers | Termination director company with name termination date | |
| 2025-09-03 | AD02 | address | Change sail address company with old address new address | |
| 2025-09-02 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-05-08 | RESOLUTIONS | resolution | Resolution | |
| 2025-04-30 | AA | accounts | Accounts with accounts type group | |
| 2025-04-28 | TM01 | officers | Termination director company with name termination date | |
| 2024-09-03 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-07-01 | SH01 | capital | Capital allotment shares | |
| 2024-05-04 | AA | accounts | Accounts with accounts type group | |
| 2024-05-02 | RESOLUTIONS | resolution | Resolution |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 13
- Capital events
- 7
- Officers appointed
- 1
- Officers resigned
- 2
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.